Analyse des parts de marché et des principaux résultats du marché des médicaments et des diagnostics basés sur le microbiome humain d'ici 2025-2031
Human Microbiome Based Drugs and Diagnostics Market Report Analysis
Human Microbiome Based Drugs and Diagnostics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Second Genome Inc
- Enterome Bioscience
- Yakult
- DuPont
- Vedanta BioSciences
- Metabiomics Corporation
- ViThera Pharmaceuticals
- MicroBiome Therapeutics LLC
- Merck
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Produit
- aliments
- probiotiques
- prébiotiques
- aliments médicaux
- dispositifs de diagnostic
- médicaments
- autres suppléments probiotiques
By Application
- Thérapeutique
- Diagnostic
By Maladie
- diarrhée aiguë
- obésité
- diabète
- troubles auto-immuns
- cancer
- troubles mentaux
- autres maladies
By Dépenses de recherche, type de produit
- instruments
- consommables
Get Free Sample For